In vitro selection of resistance to four β-lactams and azithromycin in Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 11, 1998, Pages 2914-2918

  Pankuch, Glenn A ^a   Jueneman, Shane A ^a   Davies, Todd A ^a   Jacobs, Michael R ^b   Appelbaum, Peter C ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFUROXIME; CLARITHROMYCIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; DRUG SENSITIVITY; GEL ELECTROPHORESIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 0031785122     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.11.2914     Document Type: Article

References (18)

1. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
2. Baquero, F. 1996. Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study. J. Antimicrob. Chemother. 38(Suppl. A):117-132.
3. Baquero, F., and M. C. Negri. 1997. Strategies to minimise the development of antibiotic resistance. J. Chemother. 9(Suppl. 3):29-37.
4. Breiman, R. F., J. C. Butler, F. C. Tenover, J. A. Elliott, and R. R. Facklam. 1994. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271:1831-1835.
5. Carsenti-Etesse, H., J. Durant, F. De Salvador, M. Bensoussan, F. Bensoussan, C. Pradier, A. Thabaut, and P. Dellamonica. 1995. In-vitro development of resistance to β-lactam antibiotics in Streptococcus pneumoniae. J. Antimicrob. Chemother. 36:417-423.
6. Carsenti-Etesse, H., J. Durant, P. M. Roger, M. Bensoussan, G. Mancini, A. Thabaut, and P. Dellamonica. 1995. In vitro development of resistance of Streptococcus pneumoniae (SP) by spiral method or serial passages in sub-inhibitory (subMICs) concentrations of betalactams. abstr. E11, p. 87. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
7. Carsenti-Etesse, H., P. M. Roger, G. Mancini, A. Thabaut, and P. Dellamonica. 1996. In vitro development of resistance of Streptococcus pneumoniae (SP) by spiral method in sub inhibitory (subMICs) concentrations of betalactams and macrolides, abstr. J13, p. 220. In Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
8. Doern, G. V., A. Brueggemann, H. P. Holley, Jr., and A. M. Rauch. 1996. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob. Agents Chemother. 40:1208-1213.
9. Ednie, L. M., M. A. Visalli, M. R. Jacobs, and P. C. Appelbaum. 1996. Comparative activity of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. Antimicrob. Agents Chemother. 40:1950-1952.
10. Fasola, E. L., S. Bajaksouzian, P. C. Appelbaum, and M. R. Jacobs. 1997. Variation in erythromycin and clindamycin susceptibilities of Streptococcus pneumoniae by four test methods. Antimicrob. Agents Chemother. 41:129-134.
11. Friedland, I. R., and G. H. McCracken, Jr. 1994. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N. Engl. J. Med. 331:377-382.
12. Geslin, P., A. Fremaux, G. Sissia, C. Spicq, and A. Aberrane. 1994. Epidémiologie de la résistance aux antibiotiques de Streptococcus pneumoniae en Frace. Réseau national de surveillance (1984-1993). Med. Mal. Infect. 24:948-961.
13. Jacobs, M. R. 1992. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin. Infect. Dis. 15.119-127.
14. Moissenet, D., M. Valcin, V. Marchand, E. Garabedian, P. Gelsin, A. Garbarg-Chenon, and H. Vu-Thien. 1997. Molecular epidemiology of Streptococcus pneumoniae with decreased susceptibility to penicillin in a Paris children's hospital. J. Clin. Microbiol. 35:298-301.
15. Munoz, R., T. J. Coffey, M. Daniels, C. G. Dowson, G. Laible, J. Casal, R. Hakenbeck, M. Jacobs, J. M. Musser, B. G. Spratt, and A. Tomasz. 1991. Intercontinental spread of a multiresistant clone of serotype 23F Streptococcus pneumoniae. J. Infect. Dis. 164:302-306.
16. National Committee for Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Publication no. M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
17. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.
18. Tait-Kamradt, A., J. Clancy, M. Cronan, F. Dib-Hajj, L. Wondrack, W. Yuan, and J. Sutcliffe. 1997. mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:2251-2255.